These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 25109569)
1. Translational potential of naloxone and naltrexone as TLR4 antagonists. Skolnick P; Davis H; Arnelle D; Deaver D Trends Pharmacol Sci; 2014 Sep; 35(9):431-2. PubMed ID: 25109569 [No Abstract] [Full Text] [Related]
2. In vivo veritas: (+)-Naltrexone's actions define translational importance: A letter in response to Skolnick et al. 'Translational potential of naloxone and naltrexone as TLR4 antagonists'. Watkins LR; Wang X; Mustafa S; Hutchinson MR Trends Pharmacol Sci; 2014 Sep; 35(9):432-3. PubMed ID: 25109571 [No Abstract] [Full Text] [Related]
3. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages. Franchi S; Moretti S; Castelli M; Lattuada D; Scavullo C; Panerai AE; Sacerdote P Brain Behav Immun; 2012 Mar; 26(3):480-8. PubMed ID: 22240038 [TBL] [Abstract][Full Text] [Related]
4. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Watkins LR; Hutchinson MR; Rice KC; Maier SF Trends Pharmacol Sci; 2009 Nov; 30(11):581-91. PubMed ID: 19762094 [TBL] [Abstract][Full Text] [Related]
6. Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance. Li Q Med Hypotheses; 2012 Dec; 79(6):754-6. PubMed ID: 23062774 [TBL] [Abstract][Full Text] [Related]
7. A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach. Shah M; Anwar MA; Yesudhas D; Krishnan J; Choi S Sci Rep; 2016 Dec; 6():39271. PubMed ID: 27982096 [TBL] [Abstract][Full Text] [Related]
8. The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats. Ruiz-Pérez D; Benito J; Polo G; Largo C; Aguado D; Sanz L; Gómez de Segura IA Anesth Analg; 2016 May; 122(5):1370-6. PubMed ID: 26859874 [TBL] [Abstract][Full Text] [Related]
9. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. Harris RA J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766 [TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists. Hartmann RJ; Geller I Proc West Pharmacol Soc; 1976; 19():243-7. PubMed ID: 11501 [No Abstract] [Full Text] [Related]
11. Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4. Montesinos J; Gil A; Guerri C Alcohol Clin Exp Res; 2017 Jul; 41(7):1257-1270. PubMed ID: 28493563 [TBL] [Abstract][Full Text] [Related]
20. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice. Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]